Full-Time

Pharmaceutical Sales Representative

Updated on 9/3/2026

Prism Biotech

Prism Biotech

Prelaunch prescriber profiling and targeting

Compensation Overview

$89.6k - $122.9k/yr

Little Rock, AR, USA

In Person

Category
Sales & Account Management (1)
Required Skills
Microsoft Office
Sales

Get referred to Prism Biotech

See people who can refer or advise you

Requirements
  • Ability to understand and communicate highly scientific and technical medical information.
  • Excellent communication and interpersonal skills.
  • Passion for excellence and willingness to embrace competition.
  • Demonstrated success in persuasion, influence, and negotiation.
  • Documented leadership ability.
  • Effective administrative and organizational skills, including proficiency with Microsoft Office.
Responsibilities
  • Function independently with a high degree of initiative, entrepreneurship, and autonomy while achieving short- and long-term goals.
  • Quickly gain an understanding of behavioral health and psychiatric disease states, products, market dynamics, and practice settings.
  • Comprehend product knowledge, clinical studies, protocols, and guidelines and use that knowledge to deliver information in a sales environment.
  • Develop and execute territory pharmaceutical sales business plans for assigned brands while achieving consistent sales growth within the territory.
  • Promote pharmaceutical products ethically and in compliance with the company’s sales process and approved marketing strategy.
  • Build and maintain strong pharmaceutical sales relationships with key customers across multiple settings.
  • Meet physician and patient needs while developing strong and lasting relationships with healthcare providers and their staff.
Desired Qualifications
  • Sales ability and some sales experience, although this is not required for entry-level candidates.

Prism Biotech provides field sales and medical affairs services to support pharmaceutical launches. It deploys pharmaceutical sales reps and medical science liaisons before product approval to collect prescriber information through office visits. The data gathered is combined with existing records to create a profile of key prescriber targets and disease states. This profiling happens before a launch so the sales team is prepared with identified targets and relevant physician insights. Prism Biotech differentiates itself by offering a full-service prelaunch target physician profiling workflow, aligning early market intelligence with product planning. The company’s goal is to prime and ready the sales force with accurate, ready-to-target physician profiles ahead of a brand’s approval and launch.

Company Size

N/A

Company Stage

N/A

Total Funding

N/A

Headquarters

Upper Merion Township, Pennsylvania

Founded

2019

Get referred to Prism Biotech

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Ono paid PRISM a milestone in November 2025, validating PepMetics execution.
  • E7386 Phase 1 results were published in January 2026, extending clinical credibility.
  • March 2026 Receptor.AI deal adds AI-driven discovery leverage for difficult targets.

What critics are saying

  • August 2026 nine-month loss widened to ¥845.7 million; burn remains heavy.
  • Servier terminated its collaboration in October 2025, proving partner churn hits PRISM.
  • September 2026 cash burn and no guidance set up a dilutive 2027 financing crunch.

What makes Prism Biotech unique

  • PepMetics targets intracellular protein-protein interactions, a hard, scarce drug-discovery niche.
  • PRISM BioLab monetizes by out-licensing programs to Eisai, Ono, and Servier.
  • 2026 collaborations with Receptor.AI and Talus deepen platform optionality.

Help us improve and share your feedback! Did you find this helpful?